FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
FUSN
Delisted
FUSN was delisted on the 3rd of June, 2024.
77 hedge funds and large institutions have $586M invested in Fusion Pharmaceuticals Inc. Common Shares in 2023 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 17 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
77
Holders Change
+37
Holders Change %
+92.5%
% of All Funds
1.13%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
40
Increased
17
Reduced
8
Closed
3
Calls
$592K
Puts
$172K
Net Calls
+$420K
Net Calls Change
+$420K
Top Buyers
1 |
DM
Deerfield Management
New York
|
+$34.4M |
2 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
+$10.9M |
3 |
William Blair & Company
Chicago,
Illinois
|
+$9.55M |
4 |
Wellington Management Group
Boston,
Massachusetts
|
+$7.15M |
5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$6.9M |
Top Sellers
1 |
AG
Artal Group
Luxembourg
|
-$6.91M |
2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.58M |
3 |
GTC
Ghost Tree Capital
New York
|
-$633K |
4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$591K |
5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$339K |